SLT
GILD icon

St Louis Trust’s Gilead Sciences GILD Stock Holding History

St Louis Trust’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$979K Hold
2,195
– – 0.11% 80
2026
Q1 		$306K Hold
2,195
– – 0.04% 126
2025
Q4 		$269K Hold
2,195
– – 0.03% 134
2025
Q3 		$244K Hold
2,195
– – 0.03% 112
2025
Q2 		$243K Hold
2,195
– – 0.03% 115
2025
Q1 		$246K Buy
+2,195
New +$226K 0.04% 107

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

St Louis Trust's GILD Position: Q2 2026 in Review

St Louis Trust held its Gilead Sciences (GILD) position steady in Q2 2026 at 2,195 shares worth $979K. The position accounts for 0.11% of the portfolio, ranked #80.

St Louis Trust first reported a position in GILD in Q1 2025 and has held it in 6 quarters since. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • St Louis Trust held 2,195 shares of Gilead Sciences worth $979K as of Q2 2026.
  • St Louis Trust left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.11% of St Louis Trust's portfolio in Q2 2026, its #80 holding.
  • St Louis Trust first reported a position in Gilead Sciences in Q1 2025 and has held it in 6 quarters since.
  • 2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on St Louis Trust's 13F filing for Q2 2026, filed 30 Jul 2026.